MX2017003943A - Producto farmaceutico. - Google Patents

Producto farmaceutico.

Info

Publication number
MX2017003943A
MX2017003943A MX2017003943A MX2017003943A MX2017003943A MX 2017003943 A MX2017003943 A MX 2017003943A MX 2017003943 A MX2017003943 A MX 2017003943A MX 2017003943 A MX2017003943 A MX 2017003943A MX 2017003943 A MX2017003943 A MX 2017003943A
Authority
MX
Mexico
Prior art keywords
aqueous composition
pharmaceutical product
solvate
inhibiting
salt
Prior art date
Application number
MX2017003943A
Other languages
English (en)
Inventor
Shin Sugimoto
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017003943(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kowa Co filed Critical Kowa Co
Publication of MX2017003943A publication Critical patent/MX2017003943A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Wrappers (AREA)

Abstract

Se provee una técnica para la supresión de la decoloración de una composición acuosa que contiene un derivado halogenado de isoquinolina durante la conservación a alta temperatura; una preparación farmacéutica obtenida al almacenar una composición acuosa que comprende un compuesto representado por la Fórmula (1), en donde X representa un átomo de halógeno, o una sal del mismo, o un solvato del compuesto o la sal del mismo, en un contenedor elaborado de resina a base de poliolefina. (ver Fórmula).
MX2017003943A 2014-09-25 2015-09-25 Producto farmaceutico. MX2017003943A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014194965 2014-09-25
PCT/JP2015/077014 WO2016047720A1 (ja) 2014-09-25 2015-09-25 医薬品

Publications (1)

Publication Number Publication Date
MX2017003943A true MX2017003943A (es) 2017-06-30

Family

ID=55581239

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003943A MX2017003943A (es) 2014-09-25 2015-09-25 Producto farmaceutico.

Country Status (13)

Country Link
US (1) US20170266080A1 (es)
EP (1) EP3199162B1 (es)
JP (5) JP6236167B2 (es)
KR (2) KR20180021929A (es)
CN (1) CN107073012A (es)
BR (1) BR112017006148A2 (es)
CA (1) CA2962624C (es)
ES (1) ES2909876T3 (es)
MX (1) MX2017003943A (es)
MY (1) MY179721A (es)
SG (1) SG11201702299SA (es)
TW (1) TWI686198B (es)
WO (1) WO2016047720A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017006149A2 (pt) * 2014-09-25 2017-12-26 Kowa Co preparação farmacêutica
JP7153999B2 (ja) * 2016-04-22 2022-10-17 ロート製薬株式会社 水性組成物
JP2017197526A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7159501B1 (ja) * 2016-04-22 2022-10-24 ロート製薬株式会社 眼科組成物
JP7125250B2 (ja) * 2016-04-22 2022-08-24 ロート製薬株式会社 眼科組成物
EP3446682B1 (en) * 2016-04-22 2021-05-26 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
JP2017197524A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7387835B2 (ja) * 2016-04-22 2023-11-28 ロート製薬株式会社 眼科組成物
WO2017183714A1 (ja) * 2016-04-22 2017-10-26 ロート製薬株式会社 眼科組成物
JP2017226651A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性なる組成物
KR20190119056A (ko) * 2017-02-28 2019-10-21 코와 가부시키가이샤 의약품
WO2018159701A1 (ja) * 2017-02-28 2018-09-07 興和株式会社 医薬
EP3590514A4 (en) * 2017-02-28 2021-01-06 Kowa Company, Ltd. MEDICAL PREPARATION
KR20230125086A (ko) 2017-03-27 2023-08-28 코와 가부시키가이샤 의약 제제
WO2019167183A1 (ja) * 2018-02-28 2019-09-06 興和株式会社 医薬品製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101194123B1 (ko) * 2004-03-16 2012-10-24 아사히 가세이 파마 가부시키가이샤 패수딜 함유 제제 및 그 안정성을 개선하는 방법
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006290827A (ja) * 2005-04-13 2006-10-26 Kowa Co 緑内障予防又は治療剤
JP4800720B2 (ja) * 2005-09-21 2011-10-26 興和株式会社 点眼用組成物
US20080064681A1 (en) * 2006-09-11 2008-03-13 Hiroyoshi Hidaka Therapeutic agent for treating glaucoma
KR20110022686A (ko) * 2008-07-25 2011-03-07 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물을 함유하는 안정적인 수용액 조성물
WO2015156321A1 (ja) * 2014-04-09 2015-10-15 ロート製薬株式会社 眼科組成物
BR112017006149A2 (pt) * 2014-09-25 2017-12-26 Kowa Co preparação farmacêutica
WO2016093345A1 (ja) * 2014-12-12 2016-06-16 興和株式会社 組成物

Also Published As

Publication number Publication date
CA2962624C (en) 2022-08-30
EP3199162B1 (en) 2022-03-09
EP3199162A4 (en) 2018-04-25
JP2019199483A (ja) 2019-11-21
JP2021107462A (ja) 2021-07-29
JP2018021077A (ja) 2018-02-08
WO2016047720A1 (ja) 2016-03-31
US20170266080A1 (en) 2017-09-21
BR112017006148A2 (pt) 2017-12-26
CN107073012A (zh) 2017-08-18
ES2909876T3 (es) 2022-05-10
TW201613602A (en) 2016-04-16
TWI686198B (zh) 2020-03-01
JPWO2016047720A1 (ja) 2017-06-29
JP6236167B2 (ja) 2017-11-22
KR20170063572A (ko) 2017-06-08
JP2023041805A (ja) 2023-03-24
CA2962624A1 (en) 2016-03-31
SG11201702299SA (en) 2017-04-27
KR101860279B1 (ko) 2018-05-21
EP3199162A1 (en) 2017-08-02
MY179721A (en) 2020-11-11
KR20180021929A (ko) 2018-03-05

Similar Documents

Publication Publication Date Title
TW201613602A (en) Pharmaceutical product
WO2016011390A8 (en) Irak4 inhibiting agents
PH12016500169A1 (en) Polymorph of syk inhibitors
MY194116A (en) Pharmaceutical compounds
HK1231416A1 (zh) 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
MX2017007573A (es) Composicion acuosa novedosa.
WO2016071435A3 (en) Synthesis of copanlisib and its dihydrochloride salt
MY178371A (en) Pharmaceutical preparation
MX2017007574A (es) Composicion.
EP3283453A4 (en) COATINGS AND ADDITIVES WITH FATTY ACIDS, SALTS OF FATTY ACIDS OR SIMILAR COMPOUNDS FOR USE AS DROPS AND / OR DECLARING AGENTS FOR GRANULAR PRODUCTS
MX2017007572A (es) Composicion acuosa.
IL260040A (en) Complexes of celecoxib and its salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
AU2016248025B2 (en) Polymorphs of AFATINIB and its salts and process for the preparation of quinazolinyl derivatives
MX2020012771A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
WO2015191681A3 (en) Substituted pyridinones as mgat2 inhibitors
AU2015280874A1 (en) Novel heterocyclic compound
WO2016057660A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
WO2017214423A3 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
EP3436439A4 (en) METHOD FOR PRODUCING DIPHENYLPYRAZINE DERIVATIVES
AU2018297073A1 (en) Process for the preparation of morphinane compounds
IL262490A (en) Lomacaptor complexes and their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
IL262489A (en) Complexes of ivacaptor and its salts and their history, a process for their preparation and pharmaceutical preparations containing them
IN2013MU03610A (es)